Deutsche Bank Initiates Coverage on Encompass Health (NYSE:EHC)

Share on StockTwits

Equities research analysts at Deutsche Bank started coverage on shares of Encompass Health (NYSE:EHC) in a report issued on Tuesday, Stock Target Advisor reports. The brokerage set a “hold” rating and a $70.00 price target on the stock. Deutsche Bank’s target price points to a potential upside of 10.72% from the stock’s previous close.

EHC has been the topic of a number of other reports. Bank of America raised Encompass Health to a “buy” rating in a research report on Friday, September 6th. BMO Capital Markets started coverage on Encompass Health in a research report on Thursday, June 27th. They issued an “outperform” rating and a $72.00 price target for the company. Raymond James lowered their price target on Encompass Health from $80.00 to $75.00 and set an “outperform” rating for the company in a research report on Wednesday, July 31st. Finally, Barclays raised Encompass Health from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $68.00 to $70.00 in a research report on Thursday, May 30th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Encompass Health has an average rating of “Buy” and a consensus target price of $74.60.

Shares of NYSE:EHC opened at $63.22 on Tuesday. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 1.87. Encompass Health has a twelve month low of $56.74 and a twelve month high of $80.29. The stock’s 50 day moving average is $62.18 and its 200-day moving average is $61.75. The firm has a market capitalization of $6.29 billion, a price-to-earnings ratio of 17.42, a PEG ratio of 1.89 and a beta of 0.85.

Encompass Health (NYSE:EHC) last issued its earnings results on Monday, July 29th. The company reported $1.08 earnings per share for the quarter, topping analysts’ consensus estimates of $0.97 by $0.11. Encompass Health had a return on equity of 24.10% and a net margin of 7.01%. The company had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.13 billion. Equities research analysts anticipate that Encompass Health will post 3.82 earnings per share for the current fiscal year.

About Encompass Health

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

See Also: What is the definition of market timing?

Stock Target Advisor

Analyst Recommendations for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Financial Comparison: KIMBERLY CLARK/ADR  vs. JAPAN STL WORKS/ADR
Financial Comparison: KIMBERLY CLARK/ADR vs. JAPAN STL WORKS/ADR
Critical Survey: Ocugen  vs. Its Rivals
Critical Survey: Ocugen vs. Its Rivals
Atlassian  Stock Rating Lowered by BidaskClub
Atlassian Stock Rating Lowered by BidaskClub
Qiwi  Stock Rating Lowered by BidaskClub
Qiwi Stock Rating Lowered by BidaskClub
Ituran Location and Control Ltd.   Stock Rating Upgraded by BidaskClub
Ituran Location and Control Ltd. Stock Rating Upgraded by BidaskClub
Northfield Bancorp  Rating Increased to Buy at BidaskClub
Northfield Bancorp Rating Increased to Buy at BidaskClub


© 2006-2019 Ticker Report